4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001577014-26-000004
Director sold 384,549 shares at an average $18.47 ($7,101,120)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2026-04-23 | Sale 10b5-1 | −19,261 | $19.19 | $369,619 | 1,719,356 | I |
| Rhodes Jason P Director | 2026-04-23 | Sale 10b5-1 | −38,322 | $19.19 | $735,399 | 5,221,857 | I |
| Rhodes Jason P Director | 2026-04-23 | Sale 10b5-1 | −377 | $19.19 | $7,235 | 11,286 | I |
| Rhodes Jason P Director | 2026-04-23 | Sale 10b5-1 | −15,148 | $19.19 | $290,690 | 1,270,556 | I |
| Rhodes Jason P Director | 2026-04-24 | Sale 10b5-1 | −36,345 | $18.48 | $671,656 | 1,683,011 | I |
| Rhodes Jason P Director | 2026-04-24 | Sale 10b5-1 | −72,310 | $18.48 | $1,336,289 | 5,149,547 | I |
| Rhodes Jason P Director | 2026-04-24 | Sale 10b5-1 | −710 | $18.48 | $13,121 | 10,576 | I |
| Rhodes Jason P Director | 2026-04-24 | Sale 10b5-1 | −28,583 | $18.48 | $528,214 | 1,241,973 | I |
| Rhodes Jason P Director | 2026-04-27 | Sale 10b5-1 | −45,709 | $18.15 | $829,618 | 1,637,302 | I |
| Rhodes Jason P Director | 2026-04-27 | Sale 10b5-1 | −90,943 | $18.15 | $1,650,615 | 5,058,604 | I |
| Rhodes Jason P Director | 2026-04-27 | Sale 10b5-1 | −894 | $18.15 | $16,226 | 9,682 | I |
| Rhodes Jason P Director | 2026-04-27 | Sale 10b5-1 | −35,947 | $18.15 | $652,438 | 1,206,026 | I |
| Open-market sales · 384,549 sh · avg $18.47 · $7,101,120 | |||||||
Loading xslF345X06/form4-04272026_100429.xml…